About this Journal Submit a Manuscript Table of Contents
Arthritis
Volume 2011 (2011), Article ID 146398, 5 pages
http://dx.doi.org/10.1155/2011/146398
Clinical Study

Use of Clinical Disease Activity Index Score for Assessment of Disease Activity in Rheumatoid Arthritis Patients: An Indian Experience

Department of Medicine, Pt. BDS PGIMS, Haryana Rohtak 124001, India

Received 26 August 2011; Revised 10 November 2011; Accepted 15 November 2011

Academic Editor: George D. Kitas

Copyright © 2011 H. Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Van Gestel, C. J. Haagsma, and P. L. C. M. Van Riel, “Validation of rheumatoid arthritis improvement criteria that include simplified joint counts,” Arthritis and Rheumatism, vol. 41, no. 10, pp. 1845–1850, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. F. M. Van Der Heijde, M. Van 't Hof, P. L. C. M. Van Riel, and L. B. A. Van De Putte, “Development of a disease activity score based on judgement in clinical practice by rheumatologists,” Journal of Rheumatology, vol. 20, no. 3, pp. 579–581, 1993. View at Scopus
  3. J. Fransen, M. C. W. Creemers, and P. L. C. M. Van Riel, “Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria,” Rheumatology, vol. 43, no. 10, pp. 1252–1255, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. D. Aletaha, V. P. Nell, T. Stamm et al., “Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score,” Arthritis Research & Therapy., vol. 7, no. 4, pp. R796–R806, 2005. View at Scopus
  5. J. S. Smolen, F. C. Breedveld, M. H. Schiff et al., “A simplified disease activity index for rheumatoid arthritis for use in clinical practice,” Rheumatology, vol. 42, no. 2, pp. 244–257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Smolen, J. R. Kalden, D. L. Scott et al., “Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial,” The Lancet, vol. 353, no. 9149, pp. 259–266, 1999. View at Publisher · View at Google Scholar
  7. P. Emery, F. C. Breedveld, E. M. Lemmel et al., “A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis,” Rheumatology, vol. 39, no. 6, pp. 655–665, 2000. View at Scopus
  8. V. Strand, S. Cohen, M. Schiff et al., “Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate,” Archives of Internal Medicine, vol. 159, no. 21, pp. 2542–2550, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Bombardier and P. Tugwell, “A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches,” Journal of Rheumatology, vol. 9, no. 5, pp. 753–757, 1982. View at Scopus
  10. M. Mierau, M. Schoels, G. Gonda, J. Fuchs, D. Aletaha, and J. S. Smolen, “Assessing remission in clinical practice,” Rheumatology, vol. 46, no. 6, pp. 975–979, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. Khanna, M. Oh, D. E. Furst et al., “Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort,” Arthritis Care and Research, vol. 57, no. 3, pp. 440–447, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. Misra, B. L. Sharma, R. Gupta et al., “Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis,” Indian Journal of Rheumatology, vol. 3, no. 3, pp. S1–S16, 2008. View at Scopus
  13. D. Aletaha, V. P. Nell, T. Stamm et al., “Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score,” Arthritis Research & Therapy., vol. 7, no. 4, pp. R796–R806, 2005. View at Scopus
  14. D. Aletaha and J. Smolen, “The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 23, no. 5, supplement, pp. S100–S108, 2005. View at Scopus
  15. V. Arya, A. N. Malaviya, and R. R. Raja, “CDAI (clinical disease activity index) in rheumatoid arthritis: cut-off values for classification into different grades of disease activity,” Indian Journal of Rheumatology, vol. 2, no. 3, pp. 91–94, 2007. View at Scopus
  16. J. D. Greenberg, L. R. Harrold, M. J. Bentley, J. Kremer, G. Reed, and V. Strand, “Evaluation of composite measures of treatment response without acute-phase reactants in patients with rheumatoid arthritis,” Rheumatology, vol. 48, no. 6, pp. 686–690, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. R. Günaydın, A. G. Karatepe, and T. Kaya, “The performance of the clinical disease activity index in patients with rheumatoid arthritis,” Turk Romatoloji Dergisi, vol. 21, no. 2, pp. 45–48, 2006.
  18. B. Rintelen, J. Sautner, P. M. Haindl, I. Andel, A. Maktari, and B. F. Leeb, “Comparison of three rheumatoid arthritis disease activity scores in clinical routine,” Scandinavian Journal of Rheumatology, vol. 38, no. 5, pp. 336–341, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. V. K. Ranganath, J. Yoon, D. Khanna et al., “Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort,” Annals of the Rheumatic Diseases, vol. 66, no. 12, pp. 1633–1640, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. T. S. Shaver, J. D. Anderson, D. N. Weidensaul et al., “The problem of rheumatoid arthritis disease activity and remission in clinical practice,” Journal of Rheumatology, vol. 35, no. 6, pp. 1015–1022, 2008. View at Scopus